Detalles de la búsqueda
1.
ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.
Blood
; 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427753
2.
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
Ann Hematol
; 103(2): 475-488, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695378
3.
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study).
Future Oncol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420911
4.
Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.
Hematol Oncol
; 39(1): 51-59, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32978820
5.
[Efficacy and safety of biosimilar filgrastim for autologous peripheral blood stem cell harvest and transplantation: a single-institutional retrospective analysis].
Rinsho Ketsueki
; 59(2): 145-152, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-29515065
6.
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis.
Ann Hematol
; 101(10): 2351-2352, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35751680
7.
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).
Int J Hematol
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38548963
8.
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
J Infect Chemother
; 19(6): 1126-34, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23813092
9.
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
Int J Hematol
; 117(5): 694-705, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739328
10.
[Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Rinsho Ketsueki
; 53(5): 540-2, 2012 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-22728558
11.
Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution.
Hematology
; 27(1): 360-366, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35306963
12.
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors.
Int J Hematol
; 115(6): 882-889, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397766
13.
Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single Institution.
Transplant Proc
; 53(1): 396-404, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33308840
14.
Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey.
Intern Med
; 60(5): 699-707, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33642560
15.
Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.
Int J Hematol
; 112(2): 159-168, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476083
16.
Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial.
Int J Infect Dis
; 100: 292-297, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891738
17.
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
J Clin Oncol
; 38(8): 815-822, 2020 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31977270
18.
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line.
Int J Hematol
; 111(6): 812-825, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152876
19.
[Severe liver injury following nelarabine chemotherapy for T-cell lymphoblastic lymphoma].
Rinsho Ketsueki
; 50(1): 49-51, 2009 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-19225230
20.
Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution.
Hematology
; 24(1): 355-361, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880635